Flibanserin
Back to searchMolecule Structure
Scientific Name
Flibanserin
Description of the Drug
Flibanserin is a 5-HT receptor modulator used for the treatment of selected premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04908
http://www.drugbank.ca/drugs/DB04908
Brand Name(s)
Addyi
Company Owner(s)
Sprout Pharmaceuticals Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL247579 | |
| PharmGKB | PA166153431 | |
| Human Metabolome Database | HMDB0252304 | |
| DrugBank | DB04908 | |
| PubChem: Thomson Pharma | 14805189 | |
| PubChem | 6918248 | |
| Nikkaji | J672.705K | |
| BindingDB | 50476735 | |
| DrugCentral | 5022 | |
| ChemicalBook | CB91178756 | |
| Guide to Pharmacology | 8182 | |
| rxnorm | ADDYI | FLIBANSERIN |
| PubChem: Drugs of the Future | 12014794 | |
| ChEBI | 90865 | |
| ZINC | ZINC000052716421 |
